ABVC BioPharma, Inc.
ABVC
$2.72
$0.010.37%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 108.70% | -30.60% | 50.38% | 4.10% | 87.97% |
| Total Receivables | 164.83% | -53.50% | -5.04% | -4.24% | 41.16% |
| Inventory | 0.00% | -- | -- | -- | -- |
| Prepaid Expenses | 102.28% | 0.21% | 5.37% | -9.42% | -36.84% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 13.29% | -1.30% | -2.70% | 2.26% | -1.59% |
| Total Current Assets | 88.51% | -32.58% | 1.47% | -1.89% | 22.02% |
|
|
|||||
| Total Current Assets | 88.51% | -32.58% | 1.47% | -1.89% | 22.02% |
| Net Property, Plant & Equipment | -0.32% | 655.73% | -86.36% | -1.14% | -1.40% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.73% | -0.31% | 26.49% | 0.72% | -0.25% |
| Total Assets | 9.18% | 97.29% | -47.87% | -1.17% | 1.20% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 2.85% | -6.54% | 0.84% | -3.78% | 5.73% |
| Short-term Debt | -5.02% | -6.19% | 31.93% | 8.10% | 1.20% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -48.20% | -10.26% | 0.09% | 1.08% | 7.28% |
| Total Finance Division Other Current Liabilities | 42.45% | 159.99% | -26.35% | -28.02% | -33.73% |
| Total Other Current Liabilities | 42.45% | 159.99% | -26.35% | -28.02% | -33.73% |
| Total Current Liabilities | -2.94% | 2.64% | 3.83% | -3.56% | -1.28% |
|
|
|||||
| Total Current Liabilities | -2.94% | 2.64% | 3.83% | -3.56% | -1.28% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -5.02% | -6.19% | 31.93% | 8.10% | 1.20% |
| Capital Leases | 6.05% | -29.48% | 66.53% | -37.85% | -28.10% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 92.17% | 0.00% | -15.56% | -7.22% | 27.65% |
| Total Liabilities | -2.43% | 1.52% | 5.13% | -4.73% | -2.41% |
|
|
|||||
| Common Stock & APIC | 3.31% | 6.39% | -9.98% | 0.26% | 1.23% |
| Retained Earnings | -3.23% | -1.22% | 2.27% | -0.27% | -1.46% |
| Treasury Stock & Other | 13.03% | -0.02% | -0.27% | 0.30% | 5.16% |
| Total Common Equity | 29.78% | 340.78% | -85.33% | 0.78% | 6.43% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 29.78% | 340.78% | -85.33% | 0.78% | 6.43% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -2.97% | 608.14% | -32.47% | 18.51% | -52.47% |
| Total Equity | 19.27% | 998.94% | -90.93% | 1.93% | 4.56% |
|
|
|||||